Redhill Biopharma has a total of 293 patents globally, out of which 183 have been granted. Of these 293 patents, more than 66% patents are active. United States of America is where Redhill Biopharma has filed the maximum number of patents, followed by China and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Redhill Biopharma.
Redhill Biopharma was founded in 2009. Redhill Biopharma is a biopharmaceutical company specializing in gastrointestinal diseases. They offer drugs such as Movantik for opioid-induced constipation, Talicia for Helicobacter pylori infections, and Aemcolo for travelers’ diarrhea in adults.
Do read about some of the most popular patents of Redhill Biopharma which have been covered by us in this article and also you can find Redhill Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Redhill Biopharma patent portfolio.
How many patents does Redhill Biopharma have?
Redhill Biopharma has a total of 293 patents globally. These patents belong to 20 unique patent families. Out of 293 patents, 194 patents are active.
How Many Patents did Redhill Biopharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Redhill Biopharma Applications Filed | Redhill Biopharma Patents Granted |
2024 | – | 3 |
2023 | 5 | 13 |
2022 | 3 | 4 |
2021 | 30 | 22 |
2020 | 8 | 30 |
2019 | 20 | 45 |
2018 | 20 | 14 |
2017 | 10 | 16 |
2016 | 19 | 11 |
2015 | 40 | 5 |
2014 | 54 | 2 |
How many Redhill Biopharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Redhill Biopharma File in Different Countries?
Countries in which Redhill Biopharma Filed Patents
Country | Patent |
United States of America | 50 |
China | 16 |
Japan | 14 |
Australia | 14 |
Europe (EPO) | 14 |
Canada | 12 |
Israel | 11 |
Hong Kong (S.A.R.) | 11 |
Mexico | 10 |
Korea (South) | 10 |
Brazil | 9 |
Germany | 8 |
South Africa | 8 |
Philippines | 8 |
Austria | 7 |
Russian Federation | 7 |
Singapore | 6 |
Denmark | 6 |
Chile | 5 |
Spain | 5 |
India | 5 |
Norway | 5 |
Turkey | 5 |
New Zealand | 4 |
Slovenia | 4 |
Hungary | 4 |
Poland | 4 |
Portugal | 4 |
Cyprus | 3 |
Croatia | 3 |
Indonesia | 2 |
Italy | 2 |
Slovakia | 2 |
Estonia | 1 |
United Kingdom | 1 |
Malta | 1 |
Ukraine | 1 |
Taiwan | 1 |
Where are Research Centers of Redhill Biopharma Patents Located?
10 Best Redhill Biopharma Patents
US7467202B2 is the most popular patent in the Redhill Biopharma portfolio. It has received 229 citations so far from companies like Company, Research, Mcafee.
Below is the list of 10 most cited patents of Redhill Biopharma:
Publication Number | Citation Count |
US9050263B2 | 10 |
US20140271851A1 | 8 |
US8343511B2 | 7 |
USD883801S1 | 7 |
US9498445B2 | 6 |
US10238606B2 | 5 |
US11045453B1 | 5 |
US9844540B2 | 5 |
CN110785172A | 5 |
WO2016063134A1 | 5 |
What are Redhill Biopharma key innovation segments?
What Technologies are Covered by Redhill Biopharma?
The chart below distributes patents filed by Redhill Biopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Redhill Biopharma thinks it’s important to protect particular technology inventions.
R&D Focus: How has Redhill Biopharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!